Healio

LABA/LAMA nebulized product similar to LABA/LAMA dry power inhaler in COPD

Please provide your email address to receive an email when new articles are posted on . There is a need for a nebulized LABA/LAMA formulation in COPD. Bronchodilation, pharmacokinetics and safety of a ...
Healio

Perioperative LAMA/LABA inhaled therapy optimal for patients with lung cancer, COPD

Please provide your email address to receive an email when new articles are posted on . Perioperative combination therapy using a long-acting muscarinic antagonist and long-acting beta agonist may be ...
The American Journal of Managed Care

LAMA-LABA Therapy Provides Improved Outcomes in COPD Over ICS-LABA

The findings provide further support of recommendations in the clinical guidelines to favor one therapy over the other. Patients with chronic obstructive pulmonary disease (COPD) being treated with ...
Morningstar

AeroRx Therapeutics Announces $21 Million Series A Financing to Advance Inhaled AERO-007, the First Nebulized LABA/LAMA for COPD, into Late-Stage Clinical Development

AeroRx Therapeutics, Inc., a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic respiratory diseases, today announced the closing of a $21 ...
WRIC

Boehringer Ingelheim Welcomes New 2023 GOLD Report Positioning LAMA/LABA as the Preferred Treatment for the Majority of Patients with COPD

RIDGEFIELD, Conn. and NORWALK, Conn., Nov. 17, 2022 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals Inc. welcomes the updated 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) ...
MedPage Today

Environmentally Friendlier COPD Inhaler May Also Be More Effective

There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease (COPD), according to real-world ...
Reuters

Study reassures on safety of inhaled lung treatment

LONDON (Reuters) - A major study on the safety of a mist inhaler used to treat chronic lung disease has found it does not increase the risk of patients dying early, in contrast to an earlier analysis ...
Reuters

AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion

LONDON (Reuters) - AstraZeneca is to buy U.S. respiratory drug specialist Pearl Therapeutics for up to $1.15 billion as Britain's second biggest drugmaker steps up a drive to rebuild its product ...
The American Journal of Managed Care

Implementing Inhaled Corticosteroids (ICS) into COPD Patient Treatment Regimen

Inhaled corticosteroids (ICSs) are a key incorporation to COPD treatment strategies. Jeffrey D. Dunn, PharmD, MBA: ICSs [inhaled corticosteroids] haven’t shown much evidence in impacting the course of ...
Nasdaq

Novartis receives CHMP positive opinion for Enerzair® Breezhaler® (QVM149), a potential first-in-class inhaled LABA/LAMA/ICS combination for uncontrolled asthma

Basel, May 1, 2020 — Novartis today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval ...
Monthly Prescribing Reference

Triple Therapy for Symptomatic Asthma in Patients Receiving ICS/LABA

Asthma remains one of the most prevalent chronic diseases in the US. 3 Although poor adherence substantially contributes to inadequate outcomes, even patients with high adherence often experience ...